SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 1, 2004. BioTime, Inc. (Exact name of registrant as specified in its charter) California 1-12830 94-3127919 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 935 Pardee Street Berkeley, California 94710 (Address of principal executive offices) (510) 845-9535 (Registrant's telephone number, including area code) Statements made in this Report that are not historical facts may constitute forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those discussed. Such risks and uncertainties include but are not limited to those discussed in this report and in BioTime's Annual Report on Form 10-K filed with the Securities and Exchange Commission. Words such as "expects," "may," "will," "anticipates," "intends," "plans," "believes," "seeks," "estimates," and similar expressions identify forward-looking statements. Item 5. Other Events and Regulation FD Disclosure. Jeffrey B. Nickel Ph.D was appointed to the position of Vice President of Business Development and Marketing effective June 1, 2004. Further information is incorporated by reference to Exhibit 99.1. Item 7. Financial Statements and Exhibits (c) Exhibits. Exhibit Numbers Description - ------- ----------- 99.1 Press Release dated June 1, 2004 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOTIME, INC. Date: June 3, 2004 By: /s/ Steven Seinberg -------------------------------- Steven Seinberg, Chief Financial Officer Exhibit Numbers Description - ------- ----------- 99.1 Press Release dated June 1, 2004